首页 > 最新文献

Clinical Journal of the American Society of Nephrology最新文献

英文 中文
Impact of a Longitudinal Virtual Education Series on Home Dialysis Education: A Mixed-Methods Evaluation. 纵向虚拟教育系列对家庭透析教育的影响:一种混合方法评估。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-25 DOI: 10.2215/cjn.0000000813
Wendy Wen Qing Ye,Anjali Saxena,Kerry A Leigh,Thomas A Golper,Edward R Gould,Graham Abra,Janice Lea,Joel Glickman,Shimrit Keddem,Colleen Brensinger,Jeffrey Perl,Christopher T Chan,Yuvaram N V Reddy
BACKGROUNDHome dialysis has clinical and economic benefits, yet it remains underutilized in the United States. One barrier is a lack of experience amongst fellows due to inadequate training. To enhance fellow training, the American Society of Nephrology launched the Home Dialysis Virtual Longitudinal Education Program (ASN-HDU) with Home Dialysis University (HDU) in 2023.METHODSWe evaluated the ASN-HDU longitudinal program using mixed-methods. We sampled participants from two groups: (1) fellows who attended both HDU and the ASN virtual program, and (2) fellows who only attended HDU. We sent a post-HDU survey and eight-month follow-up survey to assess quantitative changes in comfort in home dialysis. We interviewed participants from both groups and used a constant comparative method to identify qualitative themes related to home dialysis training.RESULTSAfter attending HDU, 52 participants reported median comfort levels of 7-8 out of 10 for peritoneal dialysis (PD) topics, and 4-5 out of 10 for home hemodialysis topics. In the follow-up survey, only participants of ASN-HDU demonstrated significant improvement in comfort level for all home dialysis topics by 1-2 out of 10 (except volume overload management on PD). Two main themes emerged from 10 qualitative interviews: (1) home dialysis training is sporadic and lacks structure, with subthemes describing challenges with receiving hands-on training, lack of systematic training, and a need for fellows to create their own training pathways, and (2) HDU and ASN-HDU are structured curricula that fill many educational gaps, but not all, with subthemes describing the value of these programs, examples of how fellows apply knowledge gained in clinical practice, and gaps that these curricula cannot directly address.CONCLUSIONSParticipation in ASN-HDU was associated with improved fellow comfort levels in home dialysis. Both HDU and ASN-HDU help address several gaps in home dialysis training in fellowship programs, but trainees may benefit from additional hands-on clinical experience.
背景:家庭透析具有临床和经济效益,但在美国仍未充分利用。一个障碍是由于培训不足,研究员缺乏经验。为了加强对研究员的培训,美国肾脏病学会于2023年与家庭透析大学(HDU)共同启动了家庭透析虚拟纵向教育计划(ASN-HDU)。方法采用混合方法对ASN-HDU纵向程序进行评价。我们从两组参与者中抽取样本:(1)同时参加HDU和ASN虚拟项目的参与者,(2)只参加HDU的参与者。我们进行了hdu后调查和8个月的随访调查,以评估家庭透析舒适度的定量变化。我们采访了两组的参与者,并使用恒定的比较方法来确定与家庭透析培训相关的定性主题。结果参加HDU后,52名参与者报告腹膜透析(PD)主题的中位舒适度为7-8分(满分10分),家庭血液透析主题的中位舒适度为4-5分(满分10分)。在后续调查中,只有ASN-HDU的参与者在所有家庭透析主题的舒适度方面表现出1-2 / 10的显著改善(PD的容量超载管理除外)。10次定性访谈中出现了两个主要主题:(1)家庭透析培训是零星的,缺乏结构,子主题描述了接受实践培训的挑战,缺乏系统的培训,以及需要研究员创建自己的培训途径;(2)HDU和ASN-HDU是结构化的课程,填补了许多教育空白,但不是全部,子主题描述了这些项目的价值,研究员如何在临床实践中应用知识的例子,以及这些课程不能直接解决的空白。结论:参与ASN-HDU与改善家庭透析的舒适度相关。HDU和ASN-HDU都有助于解决奖学金项目中家庭透析培训的一些空白,但受训人员可能会从额外的临床实践经验中受益。
{"title":"Impact of a Longitudinal Virtual Education Series on Home Dialysis Education: A Mixed-Methods Evaluation.","authors":"Wendy Wen Qing Ye,Anjali Saxena,Kerry A Leigh,Thomas A Golper,Edward R Gould,Graham Abra,Janice Lea,Joel Glickman,Shimrit Keddem,Colleen Brensinger,Jeffrey Perl,Christopher T Chan,Yuvaram N V Reddy","doi":"10.2215/cjn.0000000813","DOIUrl":"https://doi.org/10.2215/cjn.0000000813","url":null,"abstract":"BACKGROUNDHome dialysis has clinical and economic benefits, yet it remains underutilized in the United States. One barrier is a lack of experience amongst fellows due to inadequate training. To enhance fellow training, the American Society of Nephrology launched the Home Dialysis Virtual Longitudinal Education Program (ASN-HDU) with Home Dialysis University (HDU) in 2023.METHODSWe evaluated the ASN-HDU longitudinal program using mixed-methods. We sampled participants from two groups: (1) fellows who attended both HDU and the ASN virtual program, and (2) fellows who only attended HDU. We sent a post-HDU survey and eight-month follow-up survey to assess quantitative changes in comfort in home dialysis. We interviewed participants from both groups and used a constant comparative method to identify qualitative themes related to home dialysis training.RESULTSAfter attending HDU, 52 participants reported median comfort levels of 7-8 out of 10 for peritoneal dialysis (PD) topics, and 4-5 out of 10 for home hemodialysis topics. In the follow-up survey, only participants of ASN-HDU demonstrated significant improvement in comfort level for all home dialysis topics by 1-2 out of 10 (except volume overload management on PD). Two main themes emerged from 10 qualitative interviews: (1) home dialysis training is sporadic and lacks structure, with subthemes describing challenges with receiving hands-on training, lack of systematic training, and a need for fellows to create their own training pathways, and (2) HDU and ASN-HDU are structured curricula that fill many educational gaps, but not all, with subthemes describing the value of these programs, examples of how fellows apply knowledge gained in clinical practice, and gaps that these curricula cannot directly address.CONCLUSIONSParticipation in ASN-HDU was associated with improved fellow comfort levels in home dialysis. Both HDU and ASN-HDU help address several gaps in home dialysis training in fellowship programs, but trainees may benefit from additional hands-on clinical experience.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"86 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145140373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to: Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial. 对维持性血液透析患者跌倒风险的修正:HOPE联合试验的二次分析。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-24 DOI: 10.2215/cjn.0000000912
David M Charytan,Alvin H Moss,Manar Shalak,Wenbo Wu,Laura M Dember,Jesse Y Hsu,Natalie Kuzla,Denise Esserman,Sahir Kalim,Paul L Kimmel,Mark B Lockwood,Nobuyuki Miyawaki,Beth Pellegrino,Patrick H Pun,Rudy Qamhiyeh,Jennifer Scherer,Sarah Schrauben,Daniel E Weiner,Rajnish Mehrotra,
{"title":"Correction to: Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial.","authors":"David M Charytan,Alvin H Moss,Manar Shalak,Wenbo Wu,Laura M Dember,Jesse Y Hsu,Natalie Kuzla,Denise Esserman,Sahir Kalim,Paul L Kimmel,Mark B Lockwood,Nobuyuki Miyawaki,Beth Pellegrino,Patrick H Pun,Rudy Qamhiyeh,Jennifer Scherer,Sarah Schrauben,Daniel E Weiner,Rajnish Mehrotra, ","doi":"10.2215/cjn.0000000912","DOIUrl":"https://doi.org/10.2215/cjn.0000000912","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"28 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145127210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in Asia. 亚洲2型糖尿病患者CKD管理既定全球指南的实施
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-23 DOI: 10.2215/cjn.0000000909
Rajiv Agarwal,Masaomi Nangaku,Liming Chen,Angela Yee Moon Wang,Motoko Yanagita,Sunita Bavanandan,Bancha Satirapoj,Narayan Prasad,Soo Kun Lim,Apiradee Sriwijitkamol,Elizabeth Angelica Roasa,Boon Wee Teo,Chien-Ning Huang,Chun-Yao Huang,Carol Pollock,Sung Hee Choi,Dibya Singh Shah,Chuanming Hao,Sung Gyun Kim,Uday Jadhav,Mai-Szu Wu,Sydney Cw Tang
Worldwide, chronic kidney disease (CKD) is seen in one in nine adults; type 2 diabetes (T2D) is the most common cause. The population of just two countries in Asia, India and China, constitutes about 35% of the global population and is larger than the population of Africa or the combined populations of Europe and the Americas. CKD Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of CKD recommends the use of foundational therapies such as lifestyle modifications, detection and treatment of hypertension, and pharmacological management to forestall cardiovascular and kidney complications of T2D, including renin-angiotensin system inhibitors, sodium-glucose cotransporter 2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists such as finerenone, and glucagon-like peptide 1 receptor agonists. However, the implementation of these guidelines may be limited by real-world considerations, especially in Asia. This continent represents low-, middle-, and high-income countries and a variety of healthcare systems and policies. In this narrative review, the authors comprising of experts in the management of CKD in T2D in Asia, convened via video conferencing and online survey to discuss the perceived barriers to the implementation of guidelines with a focus on implementing the use of finerenone in CKD in T2D, particularly on the following: (1) the management of hypertension as an important comorbidity of T2D leading to CKD; (2) perceived barriers to screening for CKD in T2D; and (3) use of finerenone in T2D with CKD, including its effects on Asian patients and perceived barriers to implementing the use of finerenone in the region.
在世界范围内,每9个成年人中就有1人患有慢性肾脏疾病(CKD);2型糖尿病(T2D)是最常见的原因。仅亚洲两个国家——印度和中国的人口就占全球人口的35%左右,比非洲人口或欧洲和美洲人口的总和还要多。CKD全球结局(KDIGO) CKD评估和管理临床实践指南建议使用基础疗法,如改变生活方式,检测和治疗高血压,以及药物管理来预防T2D的心血管和肾脏并发症,包括肾素-血管紧张素系统抑制剂,钠-葡萄糖共转运蛋白2抑制剂,非甾体矿物皮质激素受体拮抗剂,如芬烯酮,和胰高血糖素样肽1受体激动剂。然而,这些指导方针的实施可能会受到现实考虑的限制,特别是在亚洲。非洲大陆有低收入、中等收入和高收入国家,有各种各样的医疗保健系统和政策。在这篇记述性综述中,作者包括亚洲T2D CKD管理专家,通过视频会议和在线调查召开会议,讨论实施指南的障碍,重点是在T2D中实施芬烯酮治疗CKD,特别是以下方面:(1)高血压作为T2D导致CKD的重要合并症的管理;(2) t2dm中CKD筛查的认知障碍;(3)芬尼酮在伴有CKD的T2D患者中的使用,包括其对亚洲患者的影响以及在该地区实施芬尼酮使用的障碍。
{"title":"Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in Asia.","authors":"Rajiv Agarwal,Masaomi Nangaku,Liming Chen,Angela Yee Moon Wang,Motoko Yanagita,Sunita Bavanandan,Bancha Satirapoj,Narayan Prasad,Soo Kun Lim,Apiradee Sriwijitkamol,Elizabeth Angelica Roasa,Boon Wee Teo,Chien-Ning Huang,Chun-Yao Huang,Carol Pollock,Sung Hee Choi,Dibya Singh Shah,Chuanming Hao,Sung Gyun Kim,Uday Jadhav,Mai-Szu Wu,Sydney Cw Tang","doi":"10.2215/cjn.0000000909","DOIUrl":"https://doi.org/10.2215/cjn.0000000909","url":null,"abstract":"Worldwide, chronic kidney disease (CKD) is seen in one in nine adults; type 2 diabetes (T2D) is the most common cause. The population of just two countries in Asia, India and China, constitutes about 35% of the global population and is larger than the population of Africa or the combined populations of Europe and the Americas. CKD Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of CKD recommends the use of foundational therapies such as lifestyle modifications, detection and treatment of hypertension, and pharmacological management to forestall cardiovascular and kidney complications of T2D, including renin-angiotensin system inhibitors, sodium-glucose cotransporter 2 inhibitors, nonsteroidal mineralocorticoid receptor antagonists such as finerenone, and glucagon-like peptide 1 receptor agonists. However, the implementation of these guidelines may be limited by real-world considerations, especially in Asia. This continent represents low-, middle-, and high-income countries and a variety of healthcare systems and policies. In this narrative review, the authors comprising of experts in the management of CKD in T2D in Asia, convened via video conferencing and online survey to discuss the perceived barriers to the implementation of guidelines with a focus on implementing the use of finerenone in CKD in T2D, particularly on the following: (1) the management of hypertension as an important comorbidity of T2D leading to CKD; (2) perceived barriers to screening for CKD in T2D; and (3) use of finerenone in T2D with CKD, including its effects on Asian patients and perceived barriers to implementing the use of finerenone in the region.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"40 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145127212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Survey Study to Assess the Diversity and Inclusion in Nephrology Journal Editorial Leadership. 评估肾脏病杂志编辑领导的多样性和包容性的调查研究。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-22 DOI: 10.2215/cjn.0000000803
Jingyao Zhang,Mariya Sesil Varghese,Rhea Gandhi,Alejandra de Jesus Sanchez,Basmh Shamel,Alejandro Valdesuso,Vineet Gupta,Tushar Chopra,Rakesh Malhotra
{"title":"A Survey Study to Assess the Diversity and Inclusion in Nephrology Journal Editorial Leadership.","authors":"Jingyao Zhang,Mariya Sesil Varghese,Rhea Gandhi,Alejandra de Jesus Sanchez,Basmh Shamel,Alejandro Valdesuso,Vineet Gupta,Tushar Chopra,Rakesh Malhotra","doi":"10.2215/cjn.0000000803","DOIUrl":"https://doi.org/10.2215/cjn.0000000803","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"24 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145127213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypothermic Perfusion Mitigates Extended Cold Ischemia Time in Kidney Transplantation. 低温灌注减轻肾移植中延长的冷缺血时间。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-19 DOI: 10.2215/cjn.0000000848
Angelica Perez-Gutierrez,Jessica Cao,Piotr Bachul,Rolf N Barth,John Fung,Rita L McGill
BACKGROUNDExtended cold ischemia time is associated with higher incidences of delayed graft function and graft failure. Kidneys on hypothermic machine perfusion perform better than comparable kidneys in static cold storage (SCS). This study aimed to determine whether hypothermic perfusion was associated with lowering the deleterious effects of extended cold ischemia time.METHODSData from the United Network of Organ Sharing database was examined to identify adult first-time, kidney-only recipients from 2005-2022. Multivariable models for death-censored graft failure, uncensored graft failure, delayed graft function, and patient mortality were constructed, and adjusted for donor, recipient, and transplant factors. Kidneys with ≤12 hours SCS, an accepted standard for optimal transplantation, served as the reference group for each model.RESULTSAmong 120,438 allografts, 63% were in SCS and 37% were preserved with hypothermic perfusion. Death-censored graft failure was higher in a dose-dependent fashion as cold ischemia time increased. Kidneys on hypothermic machine perfusion for ≤24 hours had less death-censored graft failure than reference (≤12 hours in SCS) kidneys. Perfusion for 24-36 hours did not differ from reference. After 36 hours, all kidneys had higher death-censored graft failure, regardless of the storage method. Hypothermic machine perfusion lowered the incidence of delayed graft function at every level of cold ischemia time.CONCLUSIONSHypothermic machine perfusion is an effective strategy for lowering the negative impact of prolonged cold ischemia time, providing transplant teams with greater flexibility to optimize donor and recipient logistics, without compromising long-term graft outcomes.
背景:延长冷缺血时间与移植物功能延迟和移植物衰竭的发生率增高有关。肾脏在低温机灌注比同类肾脏在静态冷库(SCS)。本研究旨在确定低温灌注是否与降低延长冷缺血时间的有害影响有关。方法研究来自美国器官共享网络数据库的数据,以确定2005-2022年成人首次纯肾受者。构建了多变量模型,包括死亡剔除的移植失败、未剔除的移植失败、延迟移植功能和患者死亡率,并根据供体、受体和移植因素进行了调整。作为最佳移植的公认标准,SCS≤12小时的肾脏作为各模型的参照组。结果120,438例同种异体移植物中,63%为SCS, 37%为低温灌注保存。随着冷缺血时间的增加,死亡审查的移植物衰竭呈剂量依赖性。低温机器灌注≤24小时的肾脏比对照(SCS≤12小时)肾脏有更少的死亡审查移植失败。灌注24-36小时与对照无差异。36小时后,无论采用何种储存方法,所有肾脏都有较高的死亡审查移植衰竭。低温机灌注降低了各冷缺血时间水平移植物功能延迟的发生率。结论热热机灌注是降低长时间冷缺血负面影响的有效策略,为移植团队提供了更大的灵活性来优化供体和受体后勤,而不会影响移植的长期效果。
{"title":"Hypothermic Perfusion Mitigates Extended Cold Ischemia Time in Kidney Transplantation.","authors":"Angelica Perez-Gutierrez,Jessica Cao,Piotr Bachul,Rolf N Barth,John Fung,Rita L McGill","doi":"10.2215/cjn.0000000848","DOIUrl":"https://doi.org/10.2215/cjn.0000000848","url":null,"abstract":"BACKGROUNDExtended cold ischemia time is associated with higher incidences of delayed graft function and graft failure. Kidneys on hypothermic machine perfusion perform better than comparable kidneys in static cold storage (SCS). This study aimed to determine whether hypothermic perfusion was associated with lowering the deleterious effects of extended cold ischemia time.METHODSData from the United Network of Organ Sharing database was examined to identify adult first-time, kidney-only recipients from 2005-2022. Multivariable models for death-censored graft failure, uncensored graft failure, delayed graft function, and patient mortality were constructed, and adjusted for donor, recipient, and transplant factors. Kidneys with ≤12 hours SCS, an accepted standard for optimal transplantation, served as the reference group for each model.RESULTSAmong 120,438 allografts, 63% were in SCS and 37% were preserved with hypothermic perfusion. Death-censored graft failure was higher in a dose-dependent fashion as cold ischemia time increased. Kidneys on hypothermic machine perfusion for ≤24 hours had less death-censored graft failure than reference (≤12 hours in SCS) kidneys. Perfusion for 24-36 hours did not differ from reference. After 36 hours, all kidneys had higher death-censored graft failure, regardless of the storage method. Hypothermic machine perfusion lowered the incidence of delayed graft function at every level of cold ischemia time.CONCLUSIONSHypothermic machine perfusion is an effective strategy for lowering the negative impact of prolonged cold ischemia time, providing transplant teams with greater flexibility to optimize donor and recipient logistics, without compromising long-term graft outcomes.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"37 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145089812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE. 同时开始使用芬尼酮和恩格列净对亚洲尿白蛋白-肌酐比率的影响:预先指定的CONFIDENCE分析。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-18 DOI: 10.2215/cjn.0000000865
Rajiv Agarwal,Jennifer B Green,Hiddo J L Heerspink,Johannes F E Mann,Janet B McGill,Amy Mottl,Takeshi Osonoi,Atanu Pal,Peter Rossing,Julio Rosenstock,Muthiah Vaduganathan,Li Li,Na Li,Charlie Scott,Pravin Manjrekar,Satoshi Yamashita,Masaomi Nangaku
{"title":"Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia: Pre-Specified Analysis of CONFIDENCE.","authors":"Rajiv Agarwal,Jennifer B Green,Hiddo J L Heerspink,Johannes F E Mann,Janet B McGill,Amy Mottl,Takeshi Osonoi,Atanu Pal,Peter Rossing,Julio Rosenstock,Muthiah Vaduganathan,Li Li,Na Li,Charlie Scott,Pravin Manjrekar,Satoshi Yamashita,Masaomi Nangaku","doi":"10.2215/cjn.0000000865","DOIUrl":"https://doi.org/10.2215/cjn.0000000865","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"71 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145077735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dietary Inflammatory Potential and Chronic Kidney Disease Risk: Exploring the Mediation Effects of Circulating Proteins. 饮食炎症潜能和慢性肾脏疾病风险:探索循环蛋白的中介作用
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-18 DOI: 10.2215/cjn.0000000847
Hee Byung Koh,Hyo Jeong Kim,Hyung Woo Kim,Young Su Joo,Seung Hyeok Han,Tae-Hyun Yoo,Shin-Wook Kang,Jung Tak Park
BACKGROUNDWhile the association between diet-induced inflammation and the risk of cardiovascular disease or cancer has been previously reported, its contribution to chronic kidney disease (CKD) and the underlying biological mechanisms remain unclear. This study aimed to elucidate the mechanistic role of the Dietary Inflammatory Index (DII) in CKD through multi-omics-based mediation analyses and to provide clinically relevant insight.METHODSThis study included 158,722 United Kingdom (UK) Biobank participants without underlying CKD (median age 57 years; 53% female). The DII was assessed via a 24-hour dietary recall and categorized into quartiles. Incident CKD was identified using International Classification of Diseases (ICD)-10 and Office of Population Censuses and Surveys Classification of Interventions and Procedures (OPCS)-4 codes. In a sub-cohort with creatinine follow-up, CKD was also defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. Mediation analyses using proteomics and metabolomics data were conducted to explore potential mechanisms linking diet-induced inflammation to CKD. Individual food item analyses were performed to identify their association with CKD via diet-induced inflammation.RESULTSDuring a median of 11.2 years of follow-up, CKD occurred in 4,382 patients. Cox regression revealed that the adjusted hazard ratios for incident CKD were higher in a stepwise fashion across higher DII quartiles (adjusted hazard ratio [aHR] and 95% confidence interval [CI]: Q2, 1.08 [0.99-1.18]; Q3, 1.15 [1.05-1.26]; Q4, 1.17 [1.06-1.29]) relative to Q1 (P-for-trend <0.001). Similar results were observed with eGFR-defined CKD. Proteomics-based mediation analysis identified death receptor and tumor necrosis factor (TNF) receptor-related proteins as mediators linking diet-induced inflammation to CKD. Metabolomics analysis highlighted omega-3 fatty acids, especially docosahexaenoic acid, as protective mediators. Oily fish intake was inversely associated with CKD risk, while sugar-rich and high-fat dairy consumption showed positive associations, partly through inflammatory pathways.CONCLUSIONSThe association between the DII and incident CKD risk may be partly mediated by alterations in circulating protein profiles involving TNF receptor superfamily-related pathways and plasma omega-3 fatty acids. Dietary counseling aimed at lowering the consumption of sugar-rich and high-fat dairy products may be beneficial.
背景:虽然饮食引起的炎症与心血管疾病或癌症风险之间的关联此前已有报道,但其对慢性肾脏疾病(CKD)的影响及其潜在的生物学机制尚不清楚。本研究旨在通过基于多组学的中介分析阐明饮食炎症指数(DII)在CKD中的机制作用,并提供临床相关的见解。方法:本研究纳入158,722名英国生物银行无潜在CKD的参与者(中位年龄57岁,53%为女性)。通过24小时饮食回顾评估DII,并将其分为四分位数。使用国际疾病分类(ICD)-10和人口普查和调查办公室干预和程序分类(OPCS)-4代码确定偶发性CKD。在肌酸酐随访的亚队列中,CKD也被定义为肾小球滤过率(eGFR) <60 mL/min/1.73 m2。利用蛋白质组学和代谢组学数据进行中介分析,探索饮食诱导炎症与CKD之间的潜在机制。对单个食物项目进行分析,以确定它们通过饮食引起的炎症与CKD的关联。结果在平均11.2年的随访期间,有4382名患者发生CKD。Cox回归显示,相对于Q1 (P-for-trend <0.001),在较高的DII四分位数中,CKD事件的校正风险比逐步升高(校正风险比[aHR]和95%置信区间[CI]: Q2, 1.08 [0.99-1.18]; Q3, 1.15 [1.05-1.26]; Q4, 1.17[1.06-1.29])。在egfr定义的CKD中也观察到类似的结果。基于蛋白质组学的中介分析发现死亡受体和肿瘤坏死因子(TNF)受体相关蛋白是饮食诱导炎症与CKD之间的中介。代谢组学分析强调了omega-3脂肪酸,特别是二十二碳六烯酸作为保护介质。油性鱼类摄入与CKD风险呈负相关,而富含糖和高脂肪的乳制品摄入则表现出正相关,部分是通过炎症途径。结论:DII与CKD发病风险之间的关联可能部分由循环蛋白谱的改变介导,包括TNF受体超家族相关途径和血浆omega-3脂肪酸。饮食咨询旨在减少高糖和高脂肪乳制品的消费可能是有益的。
{"title":"Dietary Inflammatory Potential and Chronic Kidney Disease Risk: Exploring the Mediation Effects of Circulating Proteins.","authors":"Hee Byung Koh,Hyo Jeong Kim,Hyung Woo Kim,Young Su Joo,Seung Hyeok Han,Tae-Hyun Yoo,Shin-Wook Kang,Jung Tak Park","doi":"10.2215/cjn.0000000847","DOIUrl":"https://doi.org/10.2215/cjn.0000000847","url":null,"abstract":"BACKGROUNDWhile the association between diet-induced inflammation and the risk of cardiovascular disease or cancer has been previously reported, its contribution to chronic kidney disease (CKD) and the underlying biological mechanisms remain unclear. This study aimed to elucidate the mechanistic role of the Dietary Inflammatory Index (DII) in CKD through multi-omics-based mediation analyses and to provide clinically relevant insight.METHODSThis study included 158,722 United Kingdom (UK) Biobank participants without underlying CKD (median age 57 years; 53% female). The DII was assessed via a 24-hour dietary recall and categorized into quartiles. Incident CKD was identified using International Classification of Diseases (ICD)-10 and Office of Population Censuses and Surveys Classification of Interventions and Procedures (OPCS)-4 codes. In a sub-cohort with creatinine follow-up, CKD was also defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. Mediation analyses using proteomics and metabolomics data were conducted to explore potential mechanisms linking diet-induced inflammation to CKD. Individual food item analyses were performed to identify their association with CKD via diet-induced inflammation.RESULTSDuring a median of 11.2 years of follow-up, CKD occurred in 4,382 patients. Cox regression revealed that the adjusted hazard ratios for incident CKD were higher in a stepwise fashion across higher DII quartiles (adjusted hazard ratio [aHR] and 95% confidence interval [CI]: Q2, 1.08 [0.99-1.18]; Q3, 1.15 [1.05-1.26]; Q4, 1.17 [1.06-1.29]) relative to Q1 (P-for-trend <0.001). Similar results were observed with eGFR-defined CKD. Proteomics-based mediation analysis identified death receptor and tumor necrosis factor (TNF) receptor-related proteins as mediators linking diet-induced inflammation to CKD. Metabolomics analysis highlighted omega-3 fatty acids, especially docosahexaenoic acid, as protective mediators. Oily fish intake was inversely associated with CKD risk, while sugar-rich and high-fat dairy consumption showed positive associations, partly through inflammatory pathways.CONCLUSIONSThe association between the DII and incident CKD risk may be partly mediated by alterations in circulating protein profiles involving TNF receptor superfamily-related pathways and plasma omega-3 fatty acids. Dietary counseling aimed at lowering the consumption of sugar-rich and high-fat dairy products may be beneficial.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"79 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145083578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma Proteomic Profile of Dietary Potassium and Incident Chronic Kidney Disease. 血浆蛋白质组学研究:膳食钾与慢性肾病的关系
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-18 DOI: 10.2215/cjn.0000000864
Jiaqi Yang,Lauren Bernard,Jingsha Chen,Valerie K Sullivan,Bing Yu,Eugene P Rhee,Paul A Welling,Casey M Rebholz
BACKGROUNDThere is a need for objective biomarkers of dietary potassium. The mechanisms through which dietary potassium influences kidney health are incompletely understood.METHODSAtherosclerosis Risk in Communities study participants at visit 3 (1993-1995) with dietary and proteomics data were randomly divided into discovery (N=6,814) and replication (N=3,380) sets. We examined associations between dietary potassium and 4,955 aptamers using multivariable linear regression, adjusting for sociodemographic factors, health behaviors, and estimated glomerular filtration rate, with a false discovery rate of 0.05. Then, we tested the prospective associations between potassium-related proteins and incident chronic kidney disease (CKD).RESULTSDietary potassium was significantly associated with 147 proteins in discovery, of which 85 (33 positive, 52 negative) replicated. Of 85 replicated proteins, 30 were selected by elastic net and improved prediction of high dietary potassium individually and collectively. Over a median follow-up of 21 years, 1,698 CKD cases developed. A score derived from 30 elastic net-selected dietary potassium-related proteins was associated with 7% lower risk of CKD (95% CI, 0.88-0.98, P=0.01). Of 85 potassium-related proteins from replication, 10 were associated with incident CKD. Specifically, pigment epithelium-derived factor and follistatin-related protein 3 were inversely associated with potassium and linked to 57% and 55% higher risk of CKD, respectively. Positively associated with potassium, TOM1-like protein 1 and serine/threonine-protein kinase pim-1 were associated with 28% and 26% lower risk of CKD, respectively. A score of 6 proteins mediated the association between potassium and CKD risk was associated with 13% lower risk of CKD (95% CI, 0.83-0.92, P=8.09×10-7).CONCLUSIONProteins associated with dietary potassium and incident CKD represented biological pathways including iron metabolism, mitochondrial function, fibrosis, and immune-inflammatory responses, which help explain the impact of potassium intake on CKD.
背景对膳食钾的客观生物标志物的需求。膳食钾影响肾脏健康的机制尚不完全清楚。方法随访3(1993-1995)时,有膳食和蛋白质组学资料的社区动脉粥样硬化风险研究参与者随机分为发现组(N= 6814)和重复组(N= 3380)。我们使用多变量线性回归检查了膳食钾与4,955个适体之间的关系,调整了社会人口因素、健康行为和估计的肾小球滤过率,错误发现率为0.05。然后,我们测试了钾相关蛋白与慢性肾脏疾病(CKD)发病率之间的前瞻性关联。结果发现膳食钾与147个蛋白有显著相关,其中85个蛋白(33个阳性,52个阴性)有重复。在85个复制蛋白中,通过弹性网和提高对高钾饲料的预测,分别筛选出30个。在中位随访21年期间,发生了1698例CKD病例。30种弹性净选择饮食中钾相关蛋白的评分与CKD风险降低7%相关(95% CI, 0.88-0.98, P=0.01)。来自复制的85个钾相关蛋白中,10个与CKD事件相关。具体来说,色素上皮衍生因子和卵泡抑素相关蛋白3与钾呈负相关,分别与57%和55%的CKD风险升高有关。与钾、tom1样蛋白1和丝氨酸/苏氨酸蛋白激酶pim-1呈正相关,分别与降低28%和26%的CKD风险相关。6个蛋白介导的钾与CKD风险之间的关联评分与CKD风险降低13%相关(95% CI, 0.83-0.92, P=8.09×10-7)。结论与膳食钾和CKD相关的蛋白质代表了铁代谢、线粒体功能、纤维化和免疫炎症反应等生物学途径,有助于解释钾摄入对CKD的影响。
{"title":"Plasma Proteomic Profile of Dietary Potassium and Incident Chronic Kidney Disease.","authors":"Jiaqi Yang,Lauren Bernard,Jingsha Chen,Valerie K Sullivan,Bing Yu,Eugene P Rhee,Paul A Welling,Casey M Rebholz","doi":"10.2215/cjn.0000000864","DOIUrl":"https://doi.org/10.2215/cjn.0000000864","url":null,"abstract":"BACKGROUNDThere is a need for objective biomarkers of dietary potassium. The mechanisms through which dietary potassium influences kidney health are incompletely understood.METHODSAtherosclerosis Risk in Communities study participants at visit 3 (1993-1995) with dietary and proteomics data were randomly divided into discovery (N=6,814) and replication (N=3,380) sets. We examined associations between dietary potassium and 4,955 aptamers using multivariable linear regression, adjusting for sociodemographic factors, health behaviors, and estimated glomerular filtration rate, with a false discovery rate of 0.05. Then, we tested the prospective associations between potassium-related proteins and incident chronic kidney disease (CKD).RESULTSDietary potassium was significantly associated with 147 proteins in discovery, of which 85 (33 positive, 52 negative) replicated. Of 85 replicated proteins, 30 were selected by elastic net and improved prediction of high dietary potassium individually and collectively. Over a median follow-up of 21 years, 1,698 CKD cases developed. A score derived from 30 elastic net-selected dietary potassium-related proteins was associated with 7% lower risk of CKD (95% CI, 0.88-0.98, P=0.01). Of 85 potassium-related proteins from replication, 10 were associated with incident CKD. Specifically, pigment epithelium-derived factor and follistatin-related protein 3 were inversely associated with potassium and linked to 57% and 55% higher risk of CKD, respectively. Positively associated with potassium, TOM1-like protein 1 and serine/threonine-protein kinase pim-1 were associated with 28% and 26% lower risk of CKD, respectively. A score of 6 proteins mediated the association between potassium and CKD risk was associated with 13% lower risk of CKD (95% CI, 0.83-0.92, P=8.09×10-7).CONCLUSIONProteins associated with dietary potassium and incident CKD represented biological pathways including iron metabolism, mitochondrial function, fibrosis, and immune-inflammatory responses, which help explain the impact of potassium intake on CKD.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"56 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145083471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Genetic Risk Assessment in Living Kidney Donation: A Comprehensive Approach to Patient Education and Counseling. 在活体肾脏捐献中推进遗传风险评估:患者教育和咨询的综合方法。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-17 DOI: 10.2215/cjn.0000000901
Jasmine M Akhtar,Carolyn N Sidoti,Kadiatou Diallo,Max C Downey,Samantha B Klitenic,Darren E Stewart,Karen B Vanterpool,Tamar Schiff,Jon J Snyder,Nicole M Ali,Allan B Massie,Dorry L Segev,Macey L Levan
{"title":"Advancing Genetic Risk Assessment in Living Kidney Donation: A Comprehensive Approach to Patient Education and Counseling.","authors":"Jasmine M Akhtar,Carolyn N Sidoti,Kadiatou Diallo,Max C Downey,Samantha B Klitenic,Darren E Stewart,Karen B Vanterpool,Tamar Schiff,Jon J Snyder,Nicole M Ali,Allan B Massie,Dorry L Segev,Macey L Levan","doi":"10.2215/cjn.0000000901","DOIUrl":"https://doi.org/10.2215/cjn.0000000901","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"3 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uncovering Chronic Disease Disparities Within Compacts of Free Association Migrant Populations in Hawaii. 揭示夏威夷自由联合移民人口契约中的慢性病差异。
IF 9.8 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2025-09-17 DOI: 10.2215/cjn.0000000840
Sylvia T Nguyen,Kiara L T Arakawa-Taum,Christie Izutsu,Bryan Brown
Historical events including United States (US) neocolonial administration and thermonuclear weapon testing within their homelands left many Compacts of Free Association (COFA) citizens, including those of Chuukese, Marshallese, Pohnpeian, Yapese, and Kosraean descent with poor health and educational outcomes that led to their migration to Hawai'i. A case-control study was conducted to quantify relative prevalence and severity of chronic diseases among COFA-affiliated patients compared to age- and sex-matched controls. Inclusion was based on a "Preferred Language" labeled as a COFA-affiliated language in the electronic health record. Cases and controls had received primary care at The Queen Emma Clinics, a hospital-embedded, mission-based clinic in Honolulu between January 1, 2018 through August 10, 2023. In comparison to the age- and sex-matched control group (N=1076), patients with COFA-affiliated preferred languages (N=353) had prevalence rates of diabetes mellitus two-fold higher (54% vs. 28%), chronic kidney disease 1.8-fold greater (24% vs. 14%), and history of stroke two-fold greater (13% vs. 7%) (all p<0.001). Prevalence of uncontrolled diabetes in the studied population was more than three-fold higher (16% vs 5%), and kidney failure 3.9-fold higher than that of the control group (10% vs. 3%). COFA-affiliated clinic patients had lower engagement with medical services on various indicators. COFA migrants in the US present to primary care with uniquely prevalent and advanced chronic diseases, especially type 2 diabetes mellitus and chronic kidney disease.
历史事件,包括美国的新殖民主义管理和在其本土进行的热核武器试验,使许多自由联合契约(COFA)公民,包括楚克人、马绍尔人、波纳佩人、雅浦人和Kosraean人的后裔,健康和教育状况不佳,导致他们移民到夏威夷。进行了一项病例对照研究,与年龄和性别匹配的对照组相比,量化cofa附属患者中慢性病的相对患病率和严重程度。纳入基于电子健康记录中标记为cofa附属语言的“首选语言”。2018年1月1日至2023年8月10日期间,病例和对照组在檀香山的艾玛女王诊所(Queen Emma Clinics)接受了初级护理。与年龄和性别匹配的对照组(N=1076)相比,cofa相关首选语言患者(N=353)的糖尿病患病率高2倍(54%对28%),慢性肾病患病率高1.8倍(24%对14%),卒中史患病率高2倍(13%对7%)(均p<0.001)。研究人群中未控制的糖尿病患病率比对照组高出3倍多(16%对5%),肾衰竭患病率比对照组高出3.9倍(10%对3%)。cofa附属诊所的患者在各种指标上对医疗服务的参与程度较低。在美国的COFA移民有独特的流行和晚期慢性疾病,特别是2型糖尿病和慢性肾脏疾病。
{"title":"Uncovering Chronic Disease Disparities Within Compacts of Free Association Migrant Populations in Hawaii.","authors":"Sylvia T Nguyen,Kiara L T Arakawa-Taum,Christie Izutsu,Bryan Brown","doi":"10.2215/cjn.0000000840","DOIUrl":"https://doi.org/10.2215/cjn.0000000840","url":null,"abstract":"Historical events including United States (US) neocolonial administration and thermonuclear weapon testing within their homelands left many Compacts of Free Association (COFA) citizens, including those of Chuukese, Marshallese, Pohnpeian, Yapese, and Kosraean descent with poor health and educational outcomes that led to their migration to Hawai'i. A case-control study was conducted to quantify relative prevalence and severity of chronic diseases among COFA-affiliated patients compared to age- and sex-matched controls. Inclusion was based on a \"Preferred Language\" labeled as a COFA-affiliated language in the electronic health record. Cases and controls had received primary care at The Queen Emma Clinics, a hospital-embedded, mission-based clinic in Honolulu between January 1, 2018 through August 10, 2023. In comparison to the age- and sex-matched control group (N=1076), patients with COFA-affiliated preferred languages (N=353) had prevalence rates of diabetes mellitus two-fold higher (54% vs. 28%), chronic kidney disease 1.8-fold greater (24% vs. 14%), and history of stroke two-fold greater (13% vs. 7%) (all p<0.001). Prevalence of uncontrolled diabetes in the studied population was more than three-fold higher (16% vs 5%), and kidney failure 3.9-fold higher than that of the control group (10% vs. 3%). COFA-affiliated clinic patients had lower engagement with medical services on various indicators. COFA migrants in the US present to primary care with uniquely prevalent and advanced chronic diseases, especially type 2 diabetes mellitus and chronic kidney disease.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"50 1","pages":""},"PeriodicalIF":9.8,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145071660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Journal of the American Society of Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1